支气管肺发育不良的肺移植
该研究查询 UNOS 登记(2000-2020 年)所有年龄列入或接受肺移植的患者,比较支气管肺发育不良(BPD)与其他诊断患者的等待名单结局及移植后 1、5、10 年生存。BPD 共报告 65 例,其中 32 例(49.2%)接受肺移植;BPD 患者列入时更年轻(中位 21 岁 vs 57 岁,P < .001),列入时机械通气比例更高(23% vs 3.7%,P < .001),FEV1 占预计值 17% vs 34%(P = .002)。BPD 患者移植后总体生存与其他诊断患者相似(P = .106),倾向性评分匹配后仍相似(P = .41)。作者结论认为现代 BPD 肺移植结局与其他人群相似,对进行性呼吸恶化者可考虑肺移植。
要点
- BPD 患者列入肺移植时中位年龄 21 岁(四分位距 5-31 岁),其他诊断患者为 57 岁(45-63 岁),P < .001。
- BPD 患者列入时机械通气比例 23%,其他诊断患者为 3.7%,P < .001。
- BPD 患者 FEV1 占预计值 17%,其他诊断患者为 34%,P = .002。
- BPD 患者肺移植后总体生存与其他诊断患者相似(P = .106),倾向性评分匹配后仍相似(P = .41)。
- 作者认为,对进行性呼吸恶化的 BPD 患者可考虑肺移植。
适用人群与场景
- UNOS 登记中 2000-2020 年所有年龄列入或接受肺移植的患者,比较 BPD 与其他诊断患者。
- BPD 患者中比较了前表面活性物质时代出生(pre-SE,1990 年前)与后表面活性物质时代出生(post-SE)者的移植后生存。
研究设计与关键结果
- 研究类型为 UNOS 登记数据库分析(2000-2020 年),BPD 共报告 65 例,其中 32 例(49.2%)接受肺移植。
- BPD 患者列入时中位年龄 21 岁(四分位距 5-31 岁) vs 其他诊断 57 岁(45-63 岁),P < .001。
- BPD 患者列入时机械通气比例 23% vs 其他诊断 3.7%,P < .001。
- BPD 患者 FEV1 占预计值 17% vs 其他诊断 34%,P = .002。
- BPD 患者移植后总体生存与其他诊断患者相似(P = .106),倾向性评分匹配后仍相似(P = .41)。
证据类型、等级与局限
- 证据类型:UNOS 登记数据库分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,对进行性呼吸恶化的 BPD 患者可考虑肺移植。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Patients with bronchopulmonary dysplasia (BPD) have poor respiratory trajectories and are at increased risk of lung function decline with age. Lung transplant (LTx) is a possible treatment option for this growing patient population, but little has been published on LTx in this patient group.
RESEARCH QUESTION: What are the characteristics of patients with BPD who are listed for LTx? How do waitlist and post-LTx outcomes for BPD compare with LTx for other diagnoses?
STUDY DESIGN AND METHODS: The United Network for Organ Sharing (UNOS) registry was queried for patients of all ages listed for or who underwent LTx (2000-2020). Descriptive analysis, waitlist outcomes, and post-LTx survival at 1, 5, and 10 years were assessed comparing patients with BPD vs LTx patients with other diagnoses. Post-LTx survival for patients with BPD born in the pre-surfactant era (pre-SE, before 1990) and those born in the post-surfactant era (post-SE) was compared. Propensity score matching was performed to control for the risk factors and match patients with BPD with other LTx patients on a 1:1 ratio.
RESULTS: BPD was reported in 65 patients, of whom 32 (49.2%) underwent LTx. Patients with BPD at listing were younger than those with other diagnoses (median age, 21 [interquartile range, 5-31] years vs 57 [45-63] years; P < .001), and more were likely to receive mechanical ventilation at listing (23% vs 3.7%; P < .001). Patients with BPD had an FEV1 of 17% compared with 34% predicted in other patients (P = .002). Patients with BPD had an overall similar post-LTx survival compared with patients with other diagnoses (P = .106), even following propensity score matching (P = .41).
INTERPRETATION: LTx for BPD has increased over the last 20 years. Patients with BPD have similar post-LTx outcomes compared with those of other patient populations in the modern era. Thus, LTx could be considered for patients with BPD experiencing progressive respiratory deterioration.
参考来源
- Dani A, Hayes D, Guzman-Gomez A, et al. Lung Transplantation for Bronchopulmonary Dysplasia. Chest. 2023. PMID: 36610665. doi:10.1016/j.chest.2022.12.032
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。